Experts hail bladder cancer drug 'breakthrough'
Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder cancer. Using the immunotherapy drug durvalumab before and after surgery reduced the recurrence of operable bladder cancer by a third,
‘Increased survival rates’ for bladder cancer patients given immunotherapy drug
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also being trialled in other cancers.
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patients
The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or returning when treated with immunosurpressant drug durvalumab, and were more likely to still be alive two years after treatment.
Lung cancer drug already available on NHS could cut bladder deaths
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the disease returning by a third...
Bladder cancer patients more likely to survive with new drug
Patients in the study with advanced bladder cancer had less risk of cancer progressing or returning when treated with durvalumab, currently used as a a treatment for non small cell lung cancer
News Medical on MSN40m
PIN1 protein found to be a significant driver of bladder cancer
Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...
MRI scanning and biopsy could reduce delays in correct treatment for bladder cancer by more than six weeks
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
Rolling Out4d
Signs of bladder cancer: What you should know
Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...
J&J Initiates Bid for FDA Approval of TAR-200 in Bladder Cancer
The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...
WKBW7h
'Getting poisoned': Niagara Falls neighborhood under plume of cancer-causing chemical from Goodyear Tire plant
A cancer-causing chemical is spewing into the air, in Niagara Falls, from the nearby Goodyear plant. That chemical is being ...
Pfizer's bladder cancer therapy meets main goal in late-stage study
Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...
Johnson & Johnson Initiates IND Submission Of TAR-200 To Treat High-risk Bladder Cancer
(RTTNews) - Johnson & Johnson (JNJ) Wednesday said it has initiated the submission of new drug application or NDA to Food and Drug Administration (FDA) for TAR-200 to treat patients with Bacillus ...
J&J submits NDA for TAR-200 for bladder cancer
Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.
Bladder cancer: Symptoms to look out for and when to see a doctor
Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...